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Abstract 
Introduction  
Feature selection and gene set analysis are of increasing interest in bioinformatics. While these two 
approaches have been developed for different purposes, we describe how some gene set analysis 
methods can be used to conduct feature selection. Here we adapt the gene set analysis method, 
significance analysis of microarray gene set reduction (SAMGSR), for feature selection, and propose 
two extensions – simple SAMGSR and two-level SAMGSR to identify relevant features for longitudinal 
microarray data.  
 
Results and Discussion  
When applied to a real-world application, both simple and two-level SAMGSR work comparably well. 
Using simulated data, we further demonstrate that both SAMGSR extensions have the ability to identify 
the true relevant genes. If the relevant genes are not highly correlated with the irrelevant ones, the final 
models given by the two SAMGSR extensions are parsimonious as well.   
 
Conclusions 
By adapting SAMGSR for feature selection and applying the proposed algorithms on a longitudinal gene 
expression dataset, we demonstrate that a gene set analysis method can be used for the purpose of 
feature selection. We believe this work paves the way for more research to bridge feature selection and 
gene set analysis with the development of novel algorithms. 
 
 
Keywords:  
Gene set analysis; feature selection; longitudinal microarray data; significance analysis of microarray- 
gene set reduction (SAMGSR); significance analysis of microarray (SAM) statistic.  
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Introduction  
 
Feature selection and gene set analysis are currently two tools in bioinformatics being employed with 
increasing frequency. While gene set analysis aims to identify relevant gene sets associated with a 
phenotype of interest, feature selection focuses on the identification of relevant individual genes. 
Previous studies have demonstrated that the performance of a feature selection algorithm, when 
incorporating biological information or co-expression patterns conveyed by those gene sets, is usually 
superior [1–4].  
 
Alternatively, a gene set analysis algorithm can be adopted directly to identify relevant features. For 
instance, a novel gene set analysis method called significance analysis of microarray - gene set reduction 
analysis (SAMGSR) was proposed by [5], aiming at a further reduction of selected gene set into 
respective core subsets. The concise core subsets in SAMGSR facilitate our understanding of biological 
mechanisms underlying the phenotype of interest. The reduction process can bee viewed as feature 
selection, which motivated us to adopt SAMGSR algorithm for feature selection. By applying SAMGSR 
to a real-world microarray data, we found that the resultant gene signature can distinguish multiple 
sclerosis (MS) patients apart from their controls with a good accuracy [6]. 
 
Because biological systems or processes are dynamic, researchers have been interested in investigating 
gene expression patterns longitudinally, aiming at capturing biologically meaningful dynamical changes. 
With the fast evolution of microarray technology, longitudinal microarray experiments have become 
affordable and increasingly common in different fields.  Typically, regarding to data analysis, such data 
have been tackled by stratifying the data into separate time points and analyzing them separately. This 
approach can be inefficient because it ignores the highly dependent structure of longitudinal data. Also, 
changes in gene expression pattern over time may not be detected by considering the results from 
marginal analysis at each time point individually, leading to loss in statistical power [7–9]. Consequently, 
most of the feature selection methods had been originally developed for a cross-sectional study, where 
the outcome is measured at a single time point, become ineffective for longitudinal ‘omics’ data [9].  
 
Many methods have been proposed for longitudinal gene expression data either by adapting traditional 
strategies used in longitudinal data analysis or by developing complex statistical models. For instance, 
Storey et al [7] proposed a method  designed to identify differentially expressed gene over time between 
different phenotypes. This method utilized spline-based models to estimate expression-versus-time 
curves for genes individually and a specific software program called EDGE [10] has been developed for 
implementation. However, this algorithm belongs to the simplest feature selection category –filter [11]. 
A filter method tends to select all highly correlated features into the final model, thus resulting in an 
inferior model in terms of parsimony. In their work [7], substantially a large number of genes were 
deemed as significant by EDGE, but not by t-test and SAM-test [12]. Similar phenomenon was observed 
in one recent study [13] where EDGE was applied to characterize transcriptomic difference after severe 
trauma and burn injury compared to healthy subjects, with more than 80% of genes showing significant 
differences between the two groups. Regarding to this unexpected “genomic storm”, we postulate the 
true positive rate may suffer.   
 
In this paper, we propose two extensions to SAMGSR to conduct feature selection for longitudinal 
microarray data.  First, we extend SAMGSR by applying its reduction to core subset part twice 
hierarchically.  Specifically, genes in selected gene sets are reduced to a core gene subset first and then 
time points are selected subsequently. We denote this extension the two-level SAMGSR. Second, we 
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view one specific gene over time points as a gene set. SAMGS is used to identify significant genes that 
experience change in expression values, and then SAMGSR selects at exact which time point/s 
correspond to significant difference in gene expression. This extension is named as simple SAMGSR. 
  
Methods and Materials 
Experimental Data  
Data of the real-world application were retrieved from GEO (accession number GSE36809). It was 
hybridized on Affymetrix HGU133 plus2 chips. In this cohort, there were 167 severe blunt trauma 
patients. Because our objective is to select genes that can distinguish between trauma patients with 
complications apart from those without, only patients with uncomplicated recovery and patients with 
complicated recovery were considered. The definitions for complicated and uncomplicated recovery are 
given in the original study [13]. Briefly based on the duration of recovery, uncomplicated recovery 
represents recovery within 5 days while complicated one is the recovery after 14 days, no recovery by 
28 days, or death.  
In this study, we only included those patients without complication with five time points, and patients 
with complication with seven time points. Moreover because for patients without complication their 
longest follow-up is 14 days, the data for patients with complication were truncated at 14 days. The time 
points we considered here in the training set were days 1/2, 1, 4, 7 and 14.  Lastly, we used the rest of 
complicated and uncomplicated patients as a test set to validate both algorithms. Correspondingly, the 
time points considered in the test data were days 1/2, 1, 4, and 7.   
Pre-processing Procedures   
Since different pre-processing procedures may impact analysis, we decided to download expression 
values (log2 transformed) of the experimental data from the GEO database 
(http://www.ncbi.nlm.nih.gov/geo/). We did not conduct any pre-processing. 
Pathway information   
The gene sets were downloaded from the Molecular Signatures Database (MSigDB) [14]. In this study, 
we only considered C2 category in this database, which includes gene sets from curated pathways 
databases such as KEGG [15] and those manually curated from the literature on gene expression. 
Among 17,935 unique genes in the data set, 16,121 are annotated by C2 category.  
Statistical Methods  
Here, we present a brief introduction to SAMGSR, and discuss in detail about our extensions for the 
purpose of feature selection on longitudinal gene expression data.  
SAMGSR  
SAMGSR is an extension of SAMGS [16] that provides further reduction of significant gene sets into 
respective core subsets. In SAMGSR with an approximately 90% of reduction in the size of selected 
genes, such that predictive performance is improved and biological patterns become more obvious.   
 
Briefly, SAMGSR consists of two major steps [5]. First step is essentially the SAMGS process. In this 
step, an SAM-GS statistic, the L2 norm of the SAM statistics [12] for all genes within that gene set, is 
calculated. Using a permutation test by perturbing phenotype labels to calculate p-values, statistical 
significance of a gene set is determined. Second, on those significant gene sets SAMGSR orders genes 
in gene set j based on the magnitude of its SAM statistic and then partitions gradually an entire get set 
 5 
S into two subsets: the reduced subset Rk which includes the first k genes with largest SAM statistic, and 
the residual one Rk being the complement of Rk for k=1,…, |S-1|.  Here S is the size of the specific gene 
set. Let ck be the SAMGS p-value of the residual subset Rk . The optimal size of reduced set Rk is the 
least k so that ck is larger than a pre-specified cut-off, e.g., 0.05. Conceptually, the significance of a gene 
within a gene set is determined by its contribution to the SAMGS statistic. It implies that if in a gene set 
|SAMi| > |SAMj| for genes i and j, then gene j is likely to involve in the reduce subset only when gene i 
does. 
Modifications to SAMGSR 
We propose two extensions to SAMGSR – simple SAMGSR and two-level SAMGSR to carry out 
feature selection for longitudinal microarray data.  
 
1) Two-level SAMGSR  
In this extension, the reduction procedure of SAMGSR was applied in a hierarchical way in two levels: a 
lower level on gene sets and an upper level on the time points. First, the reduction procedure of 
SAMGSR was applied to identify the reduced core subsets corresponding to the selected gene sets by 
SAMGS. Then upon the union of genes involved in those core subsets, the reduction procedure was 
applied again to determine at which time points those genes differ significantly. The main advantage of 
the two-level SAMGSR over simple SAMGSR is that it accounts for biological information contained in 
pathways (e.g., co-expression pattern). Specifically, at the gene-set level, the following SAMGS statistic 
is defined,  
 
SAMGSGSk = dij
2
j=1
ti
∑
i=1
|GSk |
∑ , dij = (xd (ij)− xc (ij)) / (s(ij)+ s0 j )  
where dij is the SAM statistic [12] of gene i (i=1,…, |GSk|) at time point j (j=1,…, ti) and |GSk| is the size 
of gene set GSk, here  k=1,…,K, and K is the total number of gene sets. This SAMGS statistic is the L2 
norm of SAM statistics accumulating over all genes inside one gene set across all time points. Then in 
the reduction step, SAMGS is calculated sequentially to a series of subsets (for the size of 1,…, |GSk|-1) 
of a significant gene set, aiming at identifying a core subset that makes essential contribute to the 
statistical significance of this gene set. This reduction part is firstly implemented upon genes, where a 
combination of a small number of genes with large values of dij2
j=1
ti
∑ is chosen. Then the algorithm moves 
to the level of time points, with the objective of determining which combination of time points 
contributes substantially to the importance of a gene, where dij is evaluated.  
 
2) Simple SAMGSR  
In this extension, we consider each gene as a gene set. Namely, a gene set consists of one specific gene 
over different time points. Our rational is that one gene’s expression values for the same individual over 
time are correlated, mimicking a gene set. First we applied SAMGSR to select the relevant genes and 
determine exactly at which time points the expression values of one specific gene differ between two 
phenotypes. A drawback of simple SAMGSR is it does not incorporate valuable biological information 
contained in pathways, which provides knowledge on how genes function in consensus to impact on 
biology processes. Figure 1 elucidates both simple and two-level SAMGSR algorithms. Then upon the 
identified genes by SAMGSR extensions, we fit support vector machine (SVM) models to compute their 
respective performance statistics.  
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Statistical Metrics  
As in the previous study [17], we used four metrics - Belief Confusion Metric (BCM), Area Under the 
Precision-Recall Curve (AUPR), Generalized Brier Score (GBS), and misclassified error rate - to 
evaluate the performance of a classifier. The references therein described those metrics in details. 
Briefly, they all range from 0 to 1. For the first two metrics the closer to 1 the better a classifier is, 
whereas the direction is opposite for the last two metrics. For longitudinal data these metrics were 
calculated at each time point.  
Statistical language and packages 
Statistical analysis was conducted in the R language version 3.1.2 (www.r-project.org), and R codes for 
SAMGSR were downloaded from (http://www.ualberta.ca/~yyasui/homepage.html). The Venn-diagram 
plot was made with the aid of an online bioinformatics tool 
(http://bioinformatics.psb.ugent.be/webtools/Venn/). R codes of simple and two-level SAMGSR 
algorithms are available upon request.   
 
Results and Discussion  
Real data  
Traumatic injury with subsequent infection was a common cause of death in ancient time. Even today 
massive injury such as combat wound remains life-threatening [18, 19]. A large clinical study that 
examined the genome-wide expression patterns of blood leukocytes in the immediate post-injury period 
was carried out recently [13]. One primary objective of that study was to explore if there were different 
patterns of gene expression associated with two extremes of clinical recovery: uncomplicated and 
complicated. The authors used the EDGE algorithm and identified 2,391 differentially expressed genes 
(DEGs) at any one point over the time course. We used the longitudinal gene expression data collected 
specifically for this objective to evaluate our proposed extensions to SAMGSR, aiming at further 
reducing the number of selected genes.  
Results of simple and two-level SAMGSR  
Based on the performance statistics in Table 1, both simple and two-level SAMGSR work comparably 
well on discriminating complicated samples from uncomplicated ones at each time point. Nevertheless, 
incorporating extra information inside gene sets results in the two-level SAMGSR having superior 
overall performance across all time points, despite its additional cost on computing time and complexity. 
Notably, those canonically curated databases on pathways/gene sets are more comprehensive for well-
studied diseases like cancers. With few work has investigated on traumatic injury using gene expression 
profiles, the implementation of gene set level on the dataset might not reflect the merit of two-level 
SAMGSR fully.    
The numbers of selected genes at these 5 time points vary, but there exists a clear pattern with the least 
number at the middle time points and largest numbers at the tails.  In Figures 2 and 3, Venn-diagrams 
illustrate how the selected genes by either SAMGSR extension at different time points overlap (Fig. 2), 
and subgroup sample mean versus time plots for those 5 genes significant across all 5 time points 
between patients with and without complications by both methods present a variety of change patterns 
over time (Fig. 3). There are two contradicted paradigms on how the host response to severe trauma: one 
is that complications were associated with multiple inflammatory events which may subsequently cause 
a secondary genomic response[20, 21]. The other is that complication results from simultaneous and 
rapid induction of innate and suppression of adaptive immunity genes [13]. (Figure 4 of the original 
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paper [13] presents the graphical illustration of these two paradigms.) Nevertheless, our analysis result 
(Fig. 3), i.e., the mixed change patterns across time points for patients with complication versus those 
without provides no clear evidence on either of these two paradigms. Further investigation is warranted.  
 
Moreover, we observe that in the 94- unique selected longitudinal gene signature by two-level 
SAMGSR, there is a substantial proportion of overlap at all time points (24/94). So is the 97- unique 
selected gene signature by simple SAMGSR (Fig. 2). In contrast, the number of genes being significant 
only at one specific time point is one half of this number. This sheds some evidence on that our 
SAMGSR extensions are capable of identifying genes that present mild but concordant difference across 
time points between two different phenotypes.  
 
Comparisons with other algorithms  
In the original work [13], 2,391 DEGs at any one point over the time course were identified using EDGE. 
In contrast, the maximum overall number of identified genes is less than one hundred by our SAMGSR 
extensions. The superiority of SAMGSR in terms of model parsimony is clear.   
 
Furthermore, using the samples being discharged early as a test set, we evaluated the performance of the 
two SAMGSR extensions versus other relevant algorithms: SAMGSR, penalized SVM, and LASSO [22] 
at each time point. The results are also presented in Table 1. Compared to other algorithms, SAMGSR 
algorithms show superior performance in terms of overall model parsimony, e.g., two-level SAMGSR 
identifies 94 unique genes while LASSO selects 147 genes. Therefore, consideration on the biology 
interactions between genes involved in pathways, maybe as well as the correlations of one gene’s 
expression over time longitudinally, might increase the capacity of excluding redundant and irrelevant 
features, without lowering predictive performance.    
  
Synthesized data  
In order to investigate the properties of both SAMGSR extensions, we used observed expression values 
from the injury application to design two sets of simulations.  
 
First, we chose two causal genes – F13A1 and GSTM1 and then randomly selected 998 genes from the 
data serving as noise. Denote the expression value of gene i (F13A1 or GSTM1) at time j (j=1,…, 5) as 
Xi.j,  the probability of an injury with complication was decided using the following logit function,  
logitc/u = 0.18XF13A1.1 + 0.57XF13A1.2 + 0.29XF13A1.3 + 0.41XF13A1.4 +1.02XGSTM1.3
 
In this set of simulations, we considered one gene whose significance arises from its moderate joint 
contribution over time and the other whose association with the outcome is large at one specific time 
point.  
 
In the second simulation, we chose two genes – COX4I2 and RP9 as the relevant genes. The logit 
function was,  
logitc/u = 0.56XCOX 4 I 2.1 − 0.91XRP9.5  
For both simulation settings, 50 replicates were created. The results are tabulated in Table 2B.  
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Interestingly, the simple SAMGSR shows no inferiority to two-level SAMGSR in both correctly 
selecting relevant genes and obtaining model parsimony. Regarding model parsimony, the inferiority of 
two-level SAMGSR might be explained by at the pathway level, a relevant gene would be involved in 
many gene sets. Then as a result, the number of highly correlated genes with the relevant ones might 
increase, with such genes end up in the final model the parsimony of two-level SAMGSR naturally 
suffers.    
 
Furthermore, although in the second simulation the number of relevant time points is less than that in the 
first one, the number of selected genes by both algorithms is dramatically larger in the second simulation.  
This might be because the relevant genes in the second simulation were highly correlated with other 
genes compared to the first simulation. The highly correlated structure between relevant features and 
irrelevant ones produces a large amount of redundant features that both SAMGSR extensions especially 
two-level one cannot exclude. To our best knowledge, however, many feature selection algorithms, 
especially those based on filtering, may suffer more from this drawback. As illustrated by our previous 
work [23, 24], an additional filtering using a relevant algorithm such as bagging [25] may alleviate this 
problem.   
 
Conclusions  
In the injury application, only patients with complications and five measurements, and patients without 
complications and with seven time points were included. With such restriction, patients discharged from 
the hospital earlier (thus having later measurements missing) were deleted, thus it might lead to 
including patients with more severe conditions. Similar to SAMGSR, our proposed extensions can 
handle missing values without any difficulty. Thus the proposed algorithms do not require this 
restriction, but we imposed this restriction to simplify our data analysis and to use partial data of those 
early-discharged patients as the test data. Since the characteristics of patients in the training set and the 
test set may be quite different, as expected the predictive errors were very high. However, the 
superiority of SAMGSR extensions in terms of model parsimony is apparent.  
 
Using a real-world microarray dataset, we demonstrated that both SAMGSR extensions account for the 
correlated structure of one expression’s profiles over time, thus tend to identify genes with longitudinal 
aggregated effects while their effect size at individual time points may be insignificant. Such genes 
would be missed when a regularization method was applied at individual time point level. This explains 
mainly why both extensions outperform in terms of model parsimony. Notably, although evaluation on 
individual time points using those statistical metrics might be unfair for both SAMGSR extensions given 
their tendency to identify those genes that are insignificant at isolated points but significant jointly over 
time, their predictive performance is comparable to other novel feature selection algorithms.        
 
The curated pathways in major databases such as KEGG and GO tend to be enriched in the most 
prevalent disease－cancers. These genes are well studied compared to those genes sorely associated 
with diseases other than cancers, potentially introducing biases into a pathway-based algorithm. One 
solution is to consider a statistical method to construct a complete set of gene subnets for all genes under 
consideration e.g., [26]. Future work on how to construct such gene sets for longitudinal microarray data 
is needed, particularly to determine whether gene sets are stable or dynamic over time. 
In this article, we adapted SAMGSR for feature selection for longitudinal gene expression profiles and 
demonstrated the application of gene set analysis methods for feature selection. Many gene set analysis 
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methods, such as [27], may also be applied directly or modified correspondingly to identify real 
‘driving’ features which characterize the phenotype of interest well.   
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Tables 
Table 1. Performance of SAMGSR extensions and comparison with other relevant algorithms 
using injury data 
 Training set Test set  
 Day 1/2 Day 1 Day 4 Day 7 Day 14 Day 1/2 Day 1 Day 4 Day 7 
A. Using two-level SAMGSR (94-gene signature, cutoff for ck = 0.2)1 
# of genes 63 55 49 63 70 63 55 49 63 
Error (%) 0 0 2.33 0 0 43.42 38.16 39.47 51.32 
GBS 0.055 0.055 0.063 0.061 0.042 0.298 0.272 0.240 0.288 
BCM  0.777 0.781 0.764 0.764 0.814 0.491 0.534 0.560 0.495 
AUPR 0.992 0.992 0.992 0.992 0.992 0.494 0.551 0.594 0.527 
B. Using simple SAMGSR  (97-gene signature, cutoff for ck = 0.2)1  
# of genes 69 53 45 77 71 69 53 45 77 
Error (%) 0 0 2.33 0 0 40.79 53.95 51.32 44.74 
GBS 0.061 0.055 0.074 0.057 0.046 0.262 0.309 0.307 0.257 
BCM  0.755 0.779 0.747 0.780 0.805 0.499 0.513 0.498 0.534 
AUPR 0.992 0.992 0.991 0.992 0.992 0.503 0.521 0.514 0.572 
C. Using SAMGSR at each time point * (the size of signature >1000, cutoff for ck = 0.1)1 
# of genes 360 30 61 42 782 360 30 61 42 
Error (%) 0 6.98 0 6.98 0 47.36 55.26 42.11 47.37 
GBS 0.066 0.085 0.051 0.074 0.055 0.264 0.295 0.266 0.296 
BCM 0.745 0.738 0.792 0.760 0.775 0.491 0.486 0.515 0.492 
AUPR 0.992 0.981 0.992 0.989 0.992 0.490 0.482 0.529 0.512 
D. Using penalized SVM at each time point  (the size of signature >1000, L1 penalty)   
# of genes 30 29 4246 6223 1030 30 29 4246 6223 
Error (%) 0 0 0 0 0 39.47 46.05 39.47 47.37 
GBS 0.078 0.083 0.071 0.072 0.068 0.256 0.280 0.242 0.237 
BCM 0.725 0.716 0.735 0.732 0.741 0.516 0.503 0.512 0.524 
AUPR 0.992 0.992 0.992 0.992 0.992 0.544 0.509 0.537 0.578 
E. Using LASSO at each time point  (147-gene signature) 
# of genes 33 29 37 28 26 33 29 37 28 
Error (%) 0 0 0 0 0 38.16 44.74 43.42 36.84 
GBS <10-4 <10-4 <10-4 <10-4 2×10-4 0.311 0.300 0.332 0.304 
BCM 0.993 0.992 0.993 0.992 0.991 0.533 0.563 0.542 0.544 
AUPR 0.992 0.992 0.992 0.992 0.992 0.522 0.583 0.546 0.588 
Note: 1 the posterior probabilities were calculated using an SVM classifier. Here, the cutoff for q-value in SAM-GS part is set at 0.05.   
 
 
Table 2. Performance of both simple SAMGSR and two-level SAMGSR on simulated data 
 Method   Time 1 Time 2 Time 3 Time 4 Time 5 
A. Simulation 1  
 # of genes 19.84 19.14 13.68 9.30 11.00 
Simple SAMGSR F13A1 (%) 72 100 100 92 68 
(Ave. # 32.06)  GSTM1 (%) 0 0 62 22 0 
 # of genes 38.88 32.66 21.44 18.96 20.50 
Two-level SAMGSR F13A1 (%) 64 92 90 84 52 
(C2: Ave. # 61.74) GSTM1 (%) 2 62 94 80 36 
B. Simulation 2  
 # of genes 182.38 56.18 35.44 30.94 123.84 
Simple SAMGSR COX4I2 (%) 96 0 0 0 4 
 13 
(Ave. # 291.98)    RP9 (%) 10 4 4 6 96 
 # of genes 209.44 73.40 48.04 49.38 138.66 
Two-level SAMGSR COX4I2 (%) 100 0 0 0 0 
(Ave. # 327.56) RP9 (%) 4 0 0 0 92 
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Figures 
Figure 1. Flowcharts illustrating both simple and two-level SAMGSR algorithms.  
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Figure 2. Characteristics of selected genes by both SAMGSR extensions in the traumatic injury 
application. A. Venn-diagram illustrates how the selected genes by simple SAMGSR method overlap at 
different time points. B. Venn-diagram illustrates how the selected genes by two-level SAMGSR 
method overlap at different time points. C. Venn-diagram illustrates how the concordantly differentially 
expressed genes across all time points by both methods overlap. 
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Figure 3. Characteristics of 5 common significant expressed genes across all time points by 
both two-level SAMGSR and simple SAMGSR in the traumatic injury application.  Subgroup 
sample means versus time plot for the 5 common genes that were identified as significance across all 5- 
time points between uncomplicated and complicated patients. Red line is for complicated group while 
black line is for uncomplicated group.  
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